在癌症药物治疗中部署的脂质纳米颗粒的批判性评估
Santanu Chakraborty1, Manami Dhibar1, Aliviya Das2
1Formulation Development Research Unit, Department of Pharmaceutics, Dr. B. C. Roy College of Pharmacy and AHS, Durgapur-713206, West Bengal, India.
Recent advances in drug delivery and formulation
|July 26, 2023
概括
脂质纳米载体为癌症治疗提供了先进的解决方案,改善了抗癌药物输送,减少了全身毒性. 本综述探讨了它们的合成,应用和安全性,以获得最佳的治疗结果.
科学领域:
- 在瘤学瘤学.
- 纳米技术纳米技术
- 药品制造 药品制造 药品制造
背景情况:
- 癌症治疗面临着传统药物输送的挑战,包括药物动力学不佳和高系统毒性.
- 新型药物输送策略对于提高抗癌疗法的疗效至关重要.
- 基于纳米技术的系统,特别是脂质纳米载体,在克服这些局限性方面显示出显著的希望.
研究的目的:
- 批判性地评估各种脂质纳米载体系统,以提供有效的抗癌药物.
- 审查脂质纳米载体的实验室和商业开发的合成方法.
- 为了说明脂质纳米载体在癌症治疗中的应用,并评估它们的安全性和毒性.
主要方法:
- 对抗癌症药物输送的脂质纳米载体系统的文献进行系统审查.
- 对脂质纳米载体的各种合成方法的分析.
- 对脂质纳米载体的应用,安全性和毒性的临床前和临床数据的评估.
主要成果:
- 脂质纳米载体表现出增强的药物加载,受控释放和改善瘤向.
- 各种合成方法使各种脂质纳米载体配方的可扩展生产成为可能.
- 研究表明,与传统方法相比,系统毒性降低,治疗疗效提高.
结论:
- 脂质纳米载体代表了先进抗癌药物递送的有希望的平台.
- 对合成优化和安全概况的进一步研究对于临床翻译至关重要.
- 这些纳米载体具有更有效,更安全的癌症治疗策略的潜力.
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K